Related Experiment Video
Updated: Jun 27, 2026
04:56
Modified Octopus Technique for Thoracoabdominal Aortic Aneurysm
Published on: August 1, 2025
Thoracic aortic aneurysm: reading the enemy's playbook
1Section of Cardiothoracic Surgery, Yale University School of Medicine, New Haven, Connecticut 06510, USA. john.elefteriades@yale.edu
The Yale Journal of Biology and Medicine
|December 23, 2008
Summary
Thoracic aortic aneurysm (TAA) is a genetic disease influenced by matrix metalloproteinase enzymes and genetic variations. Early identification of biomarkers and understanding disease progression are key to improved patient outcomes.
Area of Science:
- Cardiovascular Research
- Genetics and Genomics
- Biomarker Discovery
Background:
- Investigating the pathophysiology, clinical behavior, and management of thoracic aortic aneurysm (TAA).
- Leveraging extensive clinical experience and laboratory research at the Yale University Center for Thoracic Aortic Disease.
Purpose of the Study:
- To elucidate the underlying mechanisms and clinical progression of TAA.
- To identify genetic predispositions and potential biomarkers for TAA screening.
- To inform optimal clinical management strategies for TAA patients.
Main Methods:
- Analysis of a comprehensive Yale database of 3,000 TAA patients.
- Utilizing 9,000 patient-years of follow-up data and 9,000 imaging studies.
- Application of advanced statistical techniques to clinical and genetic data.
Main Results:
- TAA exhibits an autosomal dominant inheritance pattern, involving matrix metalloproteinase (MMP) activation.
- Wall tension in TAAs reaches critical limits around 6 cm, with 34% experiencing dissection/rupture by this size.
- Identified single nucleotide polymorphisms (SNPs) and RNA expression changes as potential biomarkers for TAA predisposition.
Conclusions:
- Scientific investigations are progressively revealing the complex nature of TAA.
- Enhanced understanding positions clinicians to more effectively manage this lethal disease.
- Biomarker identification through genetic and expression profiling offers new avenues for screening and early intervention.
Related Concept Videos
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:30Aneurysm I: Introduction
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
01:15Thoracic Aorta
The thoracic section of the aorta begins at the T5 vertebra and extends to the T12 level at the diaphragm, initially progressing through the mediastinum to the left of the spinal column. Throughout its course in the thoracic segment, the thoracic aorta emits various offshoots known collectively as visceral and parietal branches. The branches that predominantly supply blood to visceral organs are termed visceral branches and include bronchial, pericardial, esophageal, and mediastinal arteries,...
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...